Paclitaxel can be used for first-line treatment of cancers such as breast cancer, but it is not used for all types of cancer. Therefore, the statement of being the first in anti-cancer is slightly absolute.
Paclitaxel is a commonly used chemotherapeutic drug in the treatment of cancer, and is commonly used in the first-line and second-line treatment of ovarian cancer, breast cancer, non-small cell lung cancer and other cancers. In addition, it can also be used in the treatment of head and neck tumors, esophageal cancer, seminal cell carcinoma and other cancers. However, it is not the first-line chemotherapy drug for all cancers.
Note that certain side effects can occur after applying paclitaxel, such as bronchospasmic dyspnea, urticaria and other allergic reactions; neurotoxicity; cardiovascular toxicity, etc. Therefore, patients need to apply it strictly under the guidance of doctors, and should not use the drug without authorization.